HealthcareServices

Personalized Psychiatry Market Outlook 2026–2035: Growth Drivers and Industry Forecast

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the personalized psychiatry market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Personalized Psychiatry Market expected to reach by 2030?

The personalized psychiatry market size has seen rapid expansion in recent years. It is projected to increase from $6.51 billion in 2025 to $7.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.6%. Historically, this growth can be attributed to several factors including increasing awareness of mental health disorders, the expansion of genetic testing in clinical psychiatry, the rising adoption of telepsychiatry services, the growing availability of mental health data platforms, and increasing research funding for psychiatric precision medicine.

The personalized psychiatry market is set for substantial growth over the next few years, with its valuation expected to reach $12.73 billion by 2030, advancing at a compound annual growth rate (CAGR) of 14.3%. This expansion during the forecast period is fueled by an escalating demand for psychiatric interventions that yield clear outcomes, the increasing incorporation of AI and genomics within mental healthcare practices, the proliferation of home-based and digital mental wellness solutions, a heightened emphasis on individualized drug efficacy, and growing investments in platforms dedicated to precision psychiatry. Significant trends for this period include the wider adoption of treatment planning guided by pharmacogenomics, the expanding utilization of AI-powered tools for clinical decision support, the development of personalized care models through telepsychiatry, the rising integration of data from wearables and neuroimaging, and a more concentrated effort on early and accurate diagnoses.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24365&type=smp

What Drivers Are Driving Adoption Within The Personalized Psychiatry Market?

A surge in mental health concerns is projected to fuel the expansion of the personalized psychiatry market in the coming years. These issues encompass various conditions impacting an individual’s emotional, psychological, and social well-being. This rise in mental health challenges stems from heightened stress and lifestyle difficulties, often resulting from rapid work paces, inadequate work-life balance, and insufficient coping strategies. Personalized psychiatry addresses these issues through customized treatment approaches, considering each person’s unique biological, psychological, and lifestyle elements. This approach improves the efficacy of care by minimizing experimental treatment methods, which facilitates quicker recovery and better patient results. For example, US-based health agencies, specifically the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, indicated in 2025 that the prevalence of serious mental illness (SMI) among adults was approximately 5.44% in 2023. Consequently, the growing prevalence of mental health problems is stimulating the expansion of the personalized psychiatry market.

How Is The Personalized Psychiatry Market Organized Into Various Segments?

The personalized psychiatry market covered in this report is segmented –

1) By Type: Products, Services, Software

2) By Technology: Genetic Testing, Artificial Intelligence, Neurostimulation Technology, Digital Therapeutics

3) By Application: Depression, Anxiety Disorders, Bipolar Disorder, Schizophrenia, Attention-Deficit Hyperactivity Disorder (ADHD)

4) By End User: Clinics, Hospitals, Research Institutes, Homecare Settings

Subsegments:

1) By Products: Pharmacogenomic Test Kits, Wearable Devices, Brain Imaging Devices

2) By Services: Telepsychiatry, Personalized Treatment Planning, Behavioral Assessment

3) By Software: Clinical Decision Support Tools, Mental Health Apps, Virtual Therapy Platforms

Which Market Trends Are Opening Growth Opportunities In The Personalized Psychiatry Market?

Major companies operating in the personalized psychiatry market are increasingly focused on developing technologically advanced services, such as personalized telepsychiatry services, to improve access to individualized mental health care through a flexible, patient-centered model. Personalized telepsychiatry service represents a remote mental healthcare approach that delivers tailored psychiatric evaluation and treatment, based on an individual’s unique genetic, environmental, and lifestyle factors, via digital communication platforms. For instance, in April 2025, Alice’s Psychiatry & Wellness, a US-based psychiatry and wellness service company, inaugurated a clinic to offer compassionate, personalized psychiatric care to adults across multiple states, utilizing both in-person and telepsychiatry services. This clinic integrates pharmacogenetic testing to customize psychiatric medications according to each patient’s genetic profile, thereby enhancing treatment effectiveness and reducing adverse effects. The clinic leverages virtual platforms and continuous care from a dedicated provider to deliver mental health support that is accessible, consistent, and inclusive, fully aligning with the principles of personalized psychiatry.

Who Are The Top-Performing Companies In The Personalized Psychiatry Market In Recent Years?

Major companies operating in the personalized psychiatry market are Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb, Takeda Pharmaceutical Company, Boehringer Ingelheim, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Neurocrine Biosciences, Spring Health, Neumora Therapeutics Inc., Atai Life Sciences, Valera Health, Compass Pathways, Genomind, Woebot Health, Meru Health, Alto Neuroscience, Arcara Personalized Psychiatry, Mind Sync Therapeutics, Starling Minds, HMNC Holding GmbH, Pear Therapeutics, Akili Interactive

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/personalized-psychiatry-global-market-report

Which Region Currently Holds The Largest Share Of The Personalized Psychiatry Market?

North America was the largest region in the personalized psychiatry market in 2025. The regions covered in the personalized psychiatry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Personalized Psychiatry Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24365&type=smp

Browse Through More Reports Similar to the Global Personalized Psychiatry Market 2026, By The Business Research Company

General Medical And Surgical Hospitals Market Report 2026

https://www.thebusinessresearchcompany.com/report/general-medical-and-surgical-hospitals-global-market-report

Psychiatrists Market 2026

https://www.thebusinessresearchcompany.com/report/psychiatrists-market

Personalized Learning Market Report 2026

https://www.thebusinessresearchcompany.com/report/personalized-learning-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795